Clinical Trials Sponsored by Andrew Yee, MD

Total 130 results

Andrew Yee, MD
Janssen Research & Development, LLC; Amgen

Recruiting

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Multiple Myeloma | Refractory Multiple Myeloma | Relapse | Multiple Myeloma in Relapse

United States
Andrew Moses Lee, MD, PhD

Not yet recruiting

Personalized DBS for OCD Guided by Stereoencephalography Mapping

Obsessive-Compulsive Disorder | OCD

United States
Andrew Moses Lee, MD, PhD

Recruiting

Cortical Stimulation to Treat Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Andrew Pouw, MD

Recruiting

Persistence of Glaucoma Patients With Web-Browser-Based Visual Field Test

Glaucoma

United States
Andrew Pouw, MD

Completed

SmartSystem Virtual Reality Headset Perimeter Versus Humphrey HFA-III Perimeter

Glaucoma

United States
Andrew J. Armstrong, MD

Completed

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

Prostate Cancer

United States
Andrew J. Armstrong, MD

Completed

PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer (PICK-NEPC)

Prostate Cancer

United States
Andrew J. Armstrong, MD

Completed

The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer (CATCH)

Prostate Cancer

United States
Andrew VanBergen, MD

Completed

A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery (TXAEACA)

Pediatric Cardiac Surgery | Complication of Extracorporeal Circulation

United States
Andrew Sloan, MD

Completed

Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma

Brain and Central Nervous System Tumors

United States
Andrew Hendifar, MD

Completed

Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients (PanCax)

Pancreatic Neoplasms | Pancreatic Cancer | Weight Loss | Cachexia

United States
Andrew Yee, MD
Bristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.

Terminated

Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma

Refractory Multiple Myeloma | Relapsed Multiple Myeloma

United States
Andrew J. Armstrong, MD
Novartis Pharmaceuticals

Terminated

BKM120 in Metastatic Castration-resistant Prostate Cancer

Prostate Cancer | Metastatic (Spread to Other Areas of the Body)

United States
Richard W Yee, MD

Not yet recruiting

The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Andrea Roe, MD, MPH

Recruiting

Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS (RING-PCOS)

Polycystic Ovary Syndrome

United States
Andrea Rossetti, MD

Completed

Continuous EEG Randomized Trial in Adults (CERTA)

Coma | Outcome, Fatal | EEG With Abnormally Slow Frequencies | EEG With Periodic Abnormalities

Switzerland
Andrew Hendifar, MD
Yinuoke Ltd.

Recruiting

A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma (KetoROCX)

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreas Cancer

United States
Andrew Hendifar, MD
EOC Pharma

Active, not recruiting

Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma

Hepatocellular Carcinoma | Gastric Cancer

United States
Joseph Jankovic
Andrew Billnitzer, MD

Completed

Pimavanserin Treatment in TS

Tardive Dyskinesia | Tourette Syndrome

United States
Andrew Hendifar, MD
Lexicon Pharmaceuticals

Withdrawn

Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain

Pancreatic Cancer | Neuroendocrine Tumors | Cachexia; Cancer
Andrew J. Armstrong, MD
Bristol-Myers Squibb

Recruiting

A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)

Metastatic Prostate Cancer | Metastatic Prostate Neuroendocrine Carcinoma

United States
Andrew Hendifar, MD
VIVUS LLC

Recruiting

Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency (PANCAX-3)

Pancreatic Adenocarcinoma

United States
Andrew B Lassman, MD
Pfizer; AEterna Zentaris

Completed

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Glioblastoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Brain Tumor, Recurrent | Mixed Glioma

United States
Andres Iñiguez Romo, MD, PhD

Completed

Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon. (RAMSES)

Coronary Disease

Spain
Andrew B Lassman, MD
Genentech, Inc.; OSI Pharmaceuticals

Completed

EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas

Brain Cancer

United States
Andres Iñiguez Romo, MD, PhD

Completed

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI (AUREA)

Stroke | Aortic Valve Stenosis

Spain
Anders Rosengren, MD PhD

Completed

Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent
Richard W Yee, MD
Novartis Pharmaceuticals

Recruiting

The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease

Graft-versus-host-disease | Ocular Graft-versus-host Disease

United States
Claus Anders Bertelsen, PhD, MD

Completed

Non-microradical Resection Margin as a Predictor for Recurrence After Complete Mesocolic Excision

Colon Cancer
Claus Anders Bertelsen, PhD, MD

Completed

Appendicitis During the National Lockdown During the COVID-19 Pandemic

Appendicitis

Denmark
Claus Anders Bertelsen, PhD, MD

Recruiting

Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery (OPMICS)

Pain, Postoperative | Analgesia | Surgery | Colon Cancer | Injection Site | Pain, Abdominal

Denmark
Claus Anders Bertelsen, PhD, MD

Completed

Is Acute Appendicitis Still a Clinical Diagnosis?

Appendicitis
Andrew Moshfeghi, MD, MBA
Case Western Reserve University

Withdrawn

Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME

Diabetic Macular Edema
Andrew D. Barreto, MD
The University of Texas Health Science Center, Houston

Terminated

Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke (ARTSS-2)

Ischemic Stroke

United States
Andrew Hendifar, MD
Janssen Research & Development, LLC; Ipsen

Completed

Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia (OnFX)

Pancreatic Cancer | Weight Loss | Cachexia

United States
Andrew Weeks MD MRCOG
University of Liverpool; University College Hospital, Ibadan, Nigeria

Completed

Fertility Life Counselling Aid- FeLiCiA (FeLiCiA)

Depressive Disorder | Anxiety Disorders | Psychological Distress | Psychological Stress | Infertility/Sterility

Nigeria
Beeran Meghpara, MD

Recruiting

Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK)

Refractive Errors | Astigmatism | Myopia | Hypermetropia

United States
Anders Fink-Jensen, MD, DMSci

Recruiting

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Schizophrenia | Type 2 Diabetes | Metabolic Disturbance | Clozapine | Olanzapine | GLP-1

Denmark
Anders Rosengren, MD PhD
Lund University; Region Skane

Completed

Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant (YOH1)

Type 2 Diabetes

Sweden
Jason Hsu, MD

Completed

The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble

Scleral Buckling

United States
Anders Fink-Jensen, MD, DMSci

Completed

Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

Feasibility | Overweight and Obesity | Metabolic Disturbance | Mental Disorder | Liraglutide

Denmark
Anders Fink-Jensen, MD, DMSci

Terminated

COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark

Covid19 | Severe Mental Disorder

Denmark
Anders Fink-Jensen, MD, DMSci

Unknown

Does a Ketogenic Dietary Supplement Reduce Alcohol Withdrawal Symptoms in Humans? (KME)

Alcohol Use Disorder | Ketosis | Alcohol Withdrawal

Denmark
Iain Bressendorff
Ditte Hansen MD PhD; Casper Rydahl MD; Anders Nordholm MD PhD; Eva Gravesen MD PhD

Not yet recruiting

Circulating Factors in Nephrotic Syndrome

Nephrotic Syndrome | Minimal Change Disease | Membranous Nephropathy | Primary Focal Segmental Glomerulosclerosis
Loma Linda University
Charles Lee MD; Michelle Schlunt MD

Withdrawn

Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion

Postoperative Pain Management After Total Hip Arthroplasty
Anders Kvanta

Completed

Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy

Sweden
Anders Kvanta

Completed

The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study

Neovascular Age-related Macular Degeneration

Sweden
Anders Kvanta

Completed

Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen

Central Retinal Vein Occlusion

Sweden
Anders Kvanta

Completed

Bevacizumab for Central Retinal Vein Occlusion Study

Central Retinal Vein Occlusion

Sweden
Anders Kvanta

Completed

Vitrous Analysis in Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy

Sweden

Clinical Trials Sponsored by Andrew Yee, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations